SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Sanjivani Paranteral Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.`94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Company`s products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.`96 to part-finance the project. The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year` production of liquid vials and ampules. During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa, Europe & Latin America. The Company has also tied up with Cadila Ltd., Alkem Ltd., Indian Immunologicals Ltd for marketing its products. During the year 1999-2000, the company has tied-up with India`s first ranked pharmaceutical giant Ranbaxy for manufacturing its products. During 2009, the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand.
Sanjivani Paranteral share price as on 24 Jun 2025 is Rs. 220.45. Over the past 6 months, the Sanjivani Paranteral share price has decreased by 37.53% and in the last one year, it has increased by 21.59%. The 52-week low for Sanjivani Paranteral share price was Rs. 191.3 and 52-week high was Rs. 396.95.
531569
INE860D01013
Sep
Sanjivani Paranteral Ltd FAQs
You can buy Sanjivani Paranteral Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Sanjivani Paranteral Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 23, 2025 04:01 PM the closing price of Sanjivani Paranteral Ltd was Rs.220.45.
The latest PE ratio of Sanjivani Paranteral Ltd as of Jun 23, 2025 04:01 PM is 31.85
The latest PB ratio of Sanjivani Paranteral Ltd as of Jun 23, 2025 04:01 PM is 0.15
The 52-week high of Sanjivani Paranteral Ltd share price is Rs. 396.95 while the 52-week low is Rs. 191.30
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 23, 2025 04:01 PM, the market cap of Sanjivani Paranteral Ltd stood at Rs. 261.94 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.